Your browser doesn't support javascript.
loading
Dual functions of SPOP and ERG dictate androgen therapy responses in prostate cancer.
Bernasocchi, Tiziano; El Tekle, Geniver; Bolis, Marco; Mutti, Azzurra; Vallerga, Arianna; Brandt, Laura P; Spriano, Filippo; Svinkina, Tanya; Zoma, Marita; Ceserani, Valentina; Rinaldi, Anna; Janouskova, Hana; Bossi, Daniela; Cavalli, Manuela; Mosole, Simone; Geiger, Roger; Dong, Ze; Yang, Cai-Guang; Albino, Domenico; Rinaldi, Andrea; Schraml, Peter; Linder, Simon; Carbone, Giuseppina M; Alimonti, Andrea; Bertoni, Francesco; Moch, Holger; Carr, Steven A; Zwart, Wilbert; Kruithof-de Julio, Marianna; Rubin, Mark A; Udeshi, Namrata D; Theurillat, Jean-Philippe P.
Affiliation
  • Bernasocchi T; Institute of Oncology Research, Faculty of Biomedical Sciences, Università della Svizzera italiana, 6500, Bellinzona, TI, Switzerland.
  • El Tekle G; University of Lausanne, 1011, Lausanne, VD, Switzerland.
  • Bolis M; Institute of Oncology Research, Faculty of Biomedical Sciences, Università della Svizzera italiana, 6500, Bellinzona, TI, Switzerland.
  • Mutti A; University of Lausanne, 1011, Lausanne, VD, Switzerland.
  • Vallerga A; Institute of Oncology Research, Faculty of Biomedical Sciences, Università della Svizzera italiana, 6500, Bellinzona, TI, Switzerland.
  • Brandt LP; Institute of Oncology Research, Faculty of Biomedical Sciences, Università della Svizzera italiana, 6500, Bellinzona, TI, Switzerland.
  • Spriano F; Institute of Oncology Research, Faculty of Biomedical Sciences, Università della Svizzera italiana, 6500, Bellinzona, TI, Switzerland.
  • Svinkina T; Department of Biomedical Research, University of Bern, 3008, Bern, Switzerland.
  • Zoma M; Institute of Oncology Research, Faculty of Biomedical Sciences, Università della Svizzera italiana, 6500, Bellinzona, TI, Switzerland.
  • Ceserani V; University of Lausanne, 1011, Lausanne, VD, Switzerland.
  • Rinaldi A; The Broad Institute of MIT & Harvard, Cambridge, MA, 02142, USA.
  • Janouskova H; Institute of Oncology Research, Faculty of Biomedical Sciences, Università della Svizzera italiana, 6500, Bellinzona, TI, Switzerland.
  • Bossi D; University of Lausanne, 1011, Lausanne, VD, Switzerland.
  • Cavalli M; Institute of Oncology Research, Faculty of Biomedical Sciences, Università della Svizzera italiana, 6500, Bellinzona, TI, Switzerland.
  • Mosole S; Institute of Oncology Research, Faculty of Biomedical Sciences, Università della Svizzera italiana, 6500, Bellinzona, TI, Switzerland.
  • Geiger R; Institute of Oncology Research, Faculty of Biomedical Sciences, Università della Svizzera italiana, 6500, Bellinzona, TI, Switzerland.
  • Dong Z; Institute of Oncology Research, Faculty of Biomedical Sciences, Università della Svizzera italiana, 6500, Bellinzona, TI, Switzerland.
  • Yang CG; Institute of Oncology Research, Faculty of Biomedical Sciences, Università della Svizzera italiana, 6500, Bellinzona, TI, Switzerland.
  • Albino D; Institute of Oncology Research, Faculty of Biomedical Sciences, Università della Svizzera italiana, 6500, Bellinzona, TI, Switzerland.
  • Rinaldi A; Institute for Research in Biomedicine, 6500, Bellinzona, TI, Switzerland.
  • Schraml P; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 201203, Shanghai, China.
  • Linder S; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 201203, Shanghai, China.
  • Carbone GM; Institute of Oncology Research, Faculty of Biomedical Sciences, Università della Svizzera italiana, 6500, Bellinzona, TI, Switzerland.
  • Alimonti A; Institute of Oncology Research, Faculty of Biomedical Sciences, Università della Svizzera italiana, 6500, Bellinzona, TI, Switzerland.
  • Bertoni F; Department of Pathology and Molecular Pathology, University Hospital Zurich, 8091, Zurich, ZH, Switzerland.
  • Moch H; The Netherlands Cancer Institute, Oncode Institute, 1066 CX, Amsterdam, The Netherlands.
  • Carr SA; Institute of Oncology Research, Faculty of Biomedical Sciences, Università della Svizzera italiana, 6500, Bellinzona, TI, Switzerland.
  • Zwart W; Institute of Oncology Research, Faculty of Biomedical Sciences, Università della Svizzera italiana, 6500, Bellinzona, TI, Switzerland.
  • Kruithof-de Julio M; Institute of Oncology Research, Faculty of Biomedical Sciences, Università della Svizzera italiana, 6500, Bellinzona, TI, Switzerland.
  • Rubin MA; Department of Pathology and Molecular Pathology, University Hospital Zurich, 8091, Zurich, ZH, Switzerland.
  • Udeshi ND; The Broad Institute of MIT & Harvard, Cambridge, MA, 02142, USA.
  • Theurillat JP; The Netherlands Cancer Institute, Oncode Institute, 1066 CX, Amsterdam, The Netherlands.
Nat Commun ; 12(1): 734, 2021 02 02.
Article in En | MEDLINE | ID: mdl-33531470

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Repressor Proteins / Nuclear Proteins / Oncogene Proteins / Ubiquitin-Protein Ligase Complexes / Transcriptional Regulator ERG Limits: Animals / Humans / Male Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2021 Type: Article Affiliation country: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Repressor Proteins / Nuclear Proteins / Oncogene Proteins / Ubiquitin-Protein Ligase Complexes / Transcriptional Regulator ERG Limits: Animals / Humans / Male Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2021 Type: Article Affiliation country: Switzerland